Bipolar Coagulator Market is segmented By Type (Laparoscopic Surgery, Open Surgery), By End-User (Hospital, Trauma Centers, Ambulatory Surgical Centers), By Region (North America, Europe, South America, Asia-Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023- 2030.
Bipolar Coagulator Market is predicted to reach a high CAGR during the forecast period (2023- 2030). A bipolar coagulator is an electrosurgical unit used for the coagulation of blood vessels during surgery. One of the most common applications of bipolar coagulators is in female sterilization through laparoscopy. Bipolar coagulators are also popularly used in tumor removal procedures since they provide more control and flexibility during surgery.
Bipolar Coagulator Market
|
Metrics |
Details |
|
Market CAGR |
Bipolar Coagulator Market is predicted to reach a high CAGR during the forecast period (2022-2029). |
|
Segments Covered |
By Type, By End-User, and By Region |
|
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
|
Fastest Growing Region |
Asia Pacific |
|
Largest Market Share |
North America |
Market Dynamics
Bipolar coagulator market growth is driven by the increasing number of surgical procedures, increased incidences of tumors, increasing female sterilization and reduced patient burns are expected to increase demand for the bipolar coagulator market.
Increasing use in surgical procedures is expected to drive the market growth
A bipolar coagulator uses lower voltages. Thus, less energy is required. However, the amount of energy used in a low bipolar coagulator can give similar results to that of monopolar units, making bipolar coagulators more desirable during surgery. Since the current in a bipolar coagulator is restricted to the tissue between the two arms of the electrode, it gives better control and prevents damage to other sensitive areas, i.e., bipolar coagulators reduce the risk of burns in patients.
The rising number of surgical procedures taking place globally, is expected to drive the market growth
The growing number of surgical procedures taking place worldwide is expected to increase the demand for bipolar coagulators. For instance, according to Kalorama information, there are 232 million surgical procedures taking place globally as of 2016, in which 20% happens in the United States, indicating a huge healthcare market. The increasing number of surgical procedures consequently profound the market growth.
Shortage of skilled workers and time-consuming factors may hamper the market growth
Lack of skilled labor and the larger time needed due to low power setting, and tissue adherence are the major restricting factors of the market.
COVID-19 Impact Analysis
The Covid-19 outbreak in December 2021, which swarmed the entire globe in 2020, has left several economies in a dire state. With WHO issuing a public health emergency and over 40 countries declaring a state of emergency, industries, including the Global Bipolar Coagulator market, are facing many challenges. Travel bans and quarantines, halt of indoor/outdoor activities, temporary shutdown of business operations, supply-demand fluctuations, stock market volatility, falling business assurance, and many uncertainties negatively impact the business dynamics.
Segment Analysis
The laparoscopic surgery segment is expected to hold largest share in this market segment
The laparoscopic surgery segment will hold the largest share over the given time interval. This is due to the greater adoption rate of electrosurgical devices, increasing surgical procedures, fine-tuning to the nearest 0.1 W, rising occurrences of tumors, and female sterilization along with being easy to use.
The hospitals segment is expected to hold largest share in this market segment
Hospitals are predicted to foster the fastest growth in the market because of rising surgical procedures, greater use of electrosurgical equipment (due to technological advancements), higher demand by ophthalmologists, and growing instances of heart diseases. For instance, according to Kalorama information, there are 232 million surgical procedures taking place globally as of 2016, in which 20% happens in the United States, indicating a huge healthcare market.
Geographical Analysis
North America region holds the largest market share of global bipolar coagulator market
The North American region held a major market share. This is attributed to the growing investments in research and development, greater use of electrosurgical units, rising occurrences of cardiovascular diseases (where 836,546 people have died till date precisely in the North American region), presence of a large number of healthcare information technology companies in North America like B. Braun Melsungen, CVSHealth Corp., McKesson Corp., etc.
Competitive Landscape
The global bipolar coagulator market is highly competitive with presence of global companies. Some of the key players which are contributing to the growth of the market include B. Braun Melsungen AG, EMED, ALSA apparecchi medicali s.r.l., GAES MÉDICA, elektro-mag, MGB Endoskopische Geräte GmbH, SUNRAY Medical Apparatus Co., Ltd, Medgyn Products, Inc., Kirwan Surgical Products, LLC., Erbe Elektromedizin GmbH. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the market globally. For instance, In October 2019, “Apyx Medical Corporation” received U.S. FDA 510(k) clearance to advertise and trade the Apyx Plasma/RF Hand-piece.
Bipolar Coagulator Market Key Companies to Watch
B. Braun Melsungen AG
Overview: B. Braun is a German medical and pharmaceutical device company, which currently has more than 63,000 employees globally, and offices and production facilities in more than 60 countries. Its headquarters are located in Melsungen, in central Germany. The company was founded in 1839 and is still owned by the Braun family.
Product Portfolio: The Company offers Cardio-Thoracic Surgery, Continence Care & Urology, Degenerative Spinal Disorders, Diabetes Care, Extracorporeal Blood Treatment, General Open Surgery, Infection Prevention, Infusion Therapy, Interventional Vascular Diagnostics and Therapy, Laparoscopic Surgery, Neurosurgery, Nutrition Therapy, Orthopaedic Joint Replacement, Pain Therapy, Ostomy Care, Wound Management.
The global bipolar coagulator market report would provide an access to an approx. 53 market data table, 41 figures and 180 pages.
